Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | European drug pricing to affect CMO profitability and future performance, PharmSource report saysPharmSource trend report shows 'battle of formulary access' expanding to U.S.
By: PharmSource That’s the warning found in the latest trend report presented by PharmSource. The report, Not So NICE: How Market Access Schemes Impact the CMO Sector, presents detailed research and analysis of how European drug-rationing policies could affect pharmaceutical manufacturing profitability – and future operations – in Europe, the United States and elsewhere. PharmSource’ “As efforts to control soaring health-care costs continue to intensify, the battle for formulary access is expanding from Europe to the United States,” said Saul Richmond, Ph.D., director of market intelligence for PharmSource. “CMOs must become aware that these pharmaco-economic issues are increasingly important to their future prospects.” The 15-page trend report is provided as a complimentary benefit to subscribers of PharmSource Strategic Advantage service, the bio/pharmaceutical industry’s most respected outsourcing information web portal for contract drug development and manufacturing audiences. This trend report is considered required reading for CMO executives, bio/pharmaceutical sourcing and procurement executives, and private equity investors. To learn more about the report, contact PharmSource at +1.703.383.4903. PharmSource is the recognized authority of unbiased knowledge about the global bio/pharmaceutical contract services industry. The company’s publications, databases, research tools and analyses inform buyers and sellers of bio/pharma contract services about industry trends, activities and partnership opportunities. Since 1996, CMOs, CDMOs and CROs worldwide have looked to PharmSource for critical information delivered with timeliness and integrity. Learn more by visiting us online. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|